Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. Methods: We combined drug susceptibility results and molecular strain typing data with treatment outcome reports to assess the influence of drug resistance on TB treatment outcomes in a prospective cohort of patients from Abkhazia (Georgia). Patients received individualized treatment regimens based on drug susceptibility testing (DST) results. Definitions for antituberculosis drug resistance and treatment outcomes were in line with current WHO recommendations. First and second line DST, and molecular typing were performed in a supranational laboratory for Mycobacterium tuberculosis (MTB) ...
SummaryThe objectives of this study were to determine drug resistance pattern in new and previously ...
AbstractTuberculosis represents an important clinical and public health problem globally, particular...
Introduction: The burden of MDR-TB is unknown in areas that do not have drug susceptibility testing ...
Introduction Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
INTRODUCTION: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) c...
Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especia...
BACKGROUND: Data on the performance of standardized short-course directly observed treatment (DOTS) ...
Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
SummaryTuberculosis (TB) is a major infectious disease killing nearly two million people, mostly in ...
AbstractEven in the 21st century, we are losing the battle against eradication of tuberculosis (TB)....
Standard short course chemotherapy is recommended by the World Health Organization to control tuberc...
Background: Russia, together with other former Soviet Union countries, is characterized by one of th...
Globally, there is substantial concern regarding the challenges of treating complex drug resistance ...
Background: Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB...
SETTING: After the collapse of the Soviet Union, countries in the region faced a dramatic increase i...
SummaryThe objectives of this study were to determine drug resistance pattern in new and previously ...
AbstractTuberculosis represents an important clinical and public health problem globally, particular...
Introduction: The burden of MDR-TB is unknown in areas that do not have drug susceptibility testing ...
Introduction Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
INTRODUCTION: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) c...
Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especia...
BACKGROUND: Data on the performance of standardized short-course directly observed treatment (DOTS) ...
Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
SummaryTuberculosis (TB) is a major infectious disease killing nearly two million people, mostly in ...
AbstractEven in the 21st century, we are losing the battle against eradication of tuberculosis (TB)....
Standard short course chemotherapy is recommended by the World Health Organization to control tuberc...
Background: Russia, together with other former Soviet Union countries, is characterized by one of th...
Globally, there is substantial concern regarding the challenges of treating complex drug resistance ...
Background: Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB...
SETTING: After the collapse of the Soviet Union, countries in the region faced a dramatic increase i...
SummaryThe objectives of this study were to determine drug resistance pattern in new and previously ...
AbstractTuberculosis represents an important clinical and public health problem globally, particular...
Introduction: The burden of MDR-TB is unknown in areas that do not have drug susceptibility testing ...